287 related articles for article (PubMed ID: 22120494)
1. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy.
Mukhopadhyay P; Horváth B; Zsengellér Z; Zielonka J; Tanchian G; Holovac E; Kechrid M; Patel V; Stillman IE; Parikh SM; Joseph J; Kalyanaraman B; Pacher P
Free Radic Biol Med; 2012 Jan; 52(2):497-506. PubMed ID: 22120494
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.
Mukhopadhyay P; Horváth B; Zsengellėr Z; Bátkai S; Cao Z; Kechrid M; Holovac E; Erdėlyi K; Tanchian G; Liaudet L; Stillman IE; Joseph J; Kalyanaraman B; Pacher P
Free Radic Biol Med; 2012 Sep; 53(5):1123-38. PubMed ID: 22683818
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury.
Patil NK; Parajuli N; MacMillan-Crow LA; Mayeux PR
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F734-43. PubMed ID: 24500690
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
[TBL] [Abstract][Full Text] [Related]
5. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice.
Ahmed LA; Shehata NI; Abdelkader NF; Khattab MM
PLoS One; 2014; 9(10):e108889. PubMed ID: 25271439
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
[TBL] [Abstract][Full Text] [Related]
7. Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function.
Zhao C; Chen Z; Qi J; Duan S; Huang Z; Zhang C; Wu L; Zeng M; Zhang B; Wang N; Mao H; Zhang A; Xing C; Yuan Y
Oncotarget; 2017 Mar; 8(13):20988-21000. PubMed ID: 28423497
[TBL] [Abstract][Full Text] [Related]
8. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ.
Dare AJ; Bolton EA; Pettigrew GJ; Bradley JA; Saeb-Parsy K; Murphy MP
Redox Biol; 2015 Aug; 5():163-168. PubMed ID: 25965144
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
Gioscia-Ryan RA; LaRocca TJ; Sindler AL; Zigler MC; Murphy MP; Seals DR
J Physiol; 2014 Jun; 592(12):2549-61. PubMed ID: 24665093
[TBL] [Abstract][Full Text] [Related]
10. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
11. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties.
Kelso GF; Porteous CM; Coulter CV; Hughes G; Porteous WK; Ledgerwood EC; Smith RA; Murphy MP
J Biol Chem; 2001 Feb; 276(7):4588-96. PubMed ID: 11092892
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.
Starenki D; Park JI
J Clin Endocrinol Metab; 2013 Apr; 98(4):1529-40. PubMed ID: 23509102
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial NADP
Kong MJ; Han SJ; Kim JI; Park JW; Park KM
Cell Death Dis; 2018 May; 9(5):488. PubMed ID: 29695796
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
15. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
[TBL] [Abstract][Full Text] [Related]
16. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys.
Mitchell T; Rotaru D; Saba H; Smith RA; Murphy MP; MacMillan-Crow LA
J Pharmacol Exp Ther; 2011 Mar; 336(3):682-92. PubMed ID: 21159749
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.
Pan H; Shen K; Wang X; Meng H; Wang C; Jin B
PLoS One; 2014; 9(1):e86057. PubMed ID: 24454954
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity.
Zsengellér ZK; Ellezian L; Brown D; Horváth B; Mukhopadhyay P; Kalyanaraman B; Parikh SM; Karumanchi SA; Stillman IE; Pacher P
J Histochem Cytochem; 2012 Jul; 60(7):521-9. PubMed ID: 22511597
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
[TBL] [Abstract][Full Text] [Related]
20. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
Chen XJ; Wang L; Song XY
Biomed Pharmacother; 2020 May; 125():110003. PubMed ID: 32187955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
